GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pennant Group Inc (NAS:PNTG) » Definitions » Sloan Ratio %

Pennant Group (Pennant Group) Sloan Ratio % : 7.49% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pennant Group Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Pennant Group's Sloan Ratio for the quarter that ended in Mar. 2024 was 7.49%.

As of Mar. 2024, Pennant Group has a Sloan Ratio of 7.49%, indicating the company is in the safe zone and there is no funny business with accruals.


Pennant Group Sloan Ratio % Historical Data

The historical data trend for Pennant Group's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pennant Group Sloan Ratio % Chart

Pennant Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial 4.35 1.41 7.74 4.26 1.95

Pennant Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 3.88 1.95 1.95 7.49

Competitive Comparison of Pennant Group's Sloan Ratio %

For the Medical Care Facilities subindustry, Pennant Group's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pennant Group's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Pennant Group's Sloan Ratio % falls into.



Pennant Group Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Pennant Group's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(13.379-33.09
--30.222)/539.691
=1.95%

Pennant Group's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(16.435-24.639
--51.532)/578.243
=7.49%

Pennant Group's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 2.797 (Jun. 2023 ) + 4.383 (Sep. 2023 ) + 4.349 (Dec. 2023 ) + 4.906 (Mar. 2024 ) = $16.4 Mil.
Pennant Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 6.537 (Jun. 2023 ) + 12.377 (Sep. 2023 ) + 5.18 (Dec. 2023 ) + 0.545 (Mar. 2024 ) = $24.6 Mil.
Pennant Group's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -8.9 (Jun. 2023 ) + -6.35 (Sep. 2023 ) + -12.646 (Dec. 2023 ) + -23.636 (Mar. 2024 ) = $-51.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pennant Group  (NAS:PNTG) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Pennant Group has a Sloan Ratio of 7.49%, indicating the company is in the safe zone and there is no funny business with accruals.


Pennant Group Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Pennant Group's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pennant Group (Pennant Group) Business Description

Traded in Other Exchanges
Address
1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health and hospice services which includes our home health, hospice, and home care businesses and Senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The majority of the revenue is generated from the Home Health and Hospice Services segment.
Executives
Jennifer Freeman officer: Chief Financial Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Lynette Walbom officer: Chief Financial Officer 1675 E. RIVERSIDE DR., SUITE 150, EAGLE ID 83616
John J Gochnour officer: Chief Operating Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 100, EAGLE ID 83616
Joanne Stringfield director C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Barry M Smith director 4800 N SCOTTSDALE RD, SUITE 5000, SCOTTSDALE AZ 85251
John G. Nackel director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Christopher R. Christensen director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Morris Gregory K Sr. director 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Daniel H Walker director, officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Brent Guerisoli officer: President 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Derek J Bunker officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Scott E Lamb director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Roderic W Lewis director
Covey Stephen M R director
Ensign Group, Inc 10 percent owner 29222 RANCHO VIEJO RD., SUITE 127, SAN JUAN CAPISTRANO CA 92675

Pennant Group (Pennant Group) Headlines

From GuruFocus

Pennant Announces Third Quarter 2022 Earnings Release and Call

By Value_Insider Value_Insider 11-03-2022

Pennant to Participate in the 2022 Stephens Annual Investment Conference

By Value_Insider Value_Insider 11-11-2022

The Pennant Group Reorganizes Executive Team

By Value_Insider Value_Insider 11-15-2022

Pennant to Present at the 2022 RBC Global Healthcare Conference

By GuruFocusNews GuruFocusNews 07-05-2022

Pennant to Present at the 2022 RBC Global Healthcare Conference

By PurpleRose PurpleRose 07-15-2022

Pennant Announces First Quarter 2023 Earnings Release and Call

By sperokesalga sperokesalga 04-21-2023

Pennant Acquires Senior Living Operations in Wisconsin

By sperokesalga sperokesalga 03-20-2023